Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Hematology|September 11, 2023
Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell LymphomaNathan Visweshwar, Juan Felipe Rico, Robert Killeen, et al.Case Reports in Hematology|July 23, 2015
Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin TherapyTerry Golombick, Terrence H Diamond, Arumugam Manoharan, et al.Integrative Cancer Therapies|December 18, 2015
B-Cell Disorders and CurcuminTerry Golombick, Terrence H Diamond, Arumugam Manoharan, et al.British Journal of Haematology|February 27, 2004
Percutaneous vertebroplasty for acute vertebral body fracture and deformity in multiple myeloma: a short reportTerrence H Diamond, Tabitha Hartwell, William Clarke, et al.International Journal of Hematology|July 4, 2002
Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukemiaArumugam Manoharan, Annette Trickett, Yiu Lam Kwan, et al.American Journal of Hematology|April 5, 2012
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension studyTerry Golombick, Terrence H Diamond, Arumugam Manoharan, et al.Journal of Hematology|March 1, 2021
Use of a Mobile Intermittent Pneumatic Compression Device (Vekroosan) in Mobile Patients With Chronic Venous DiseaseRaj Ramakrishna, William Alexander, Lina BaytiehMolecules (Basel, Switzerland)|October 14, 2022
Polyphenol-Rich Ginger (Zingiber officinale) for Iron Deficiency Anaemia and Other Clinical Entities Associated with Altered Iron MetabolismSoo Liang Ooi, Sok Cheon Pak, Ron Campbell, et al.Clinical Case Reports|April 11, 2020
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapyRajeev Ramakrishna, Terrence H Diamond, William Alexander, et al.Clinical Medicine Insights. Blood Disorders|November 18, 2017
Effect of the Ginger Derivative, 6-Shogaol, on Ferritin Levels in Patients With Low to Intermediate-1-Risk Myelodysplastic Syndrome-A Small, Investigative StudyTerry Golombick, Terrence H Diamond, Arumugam Manoharan, et al.Pageof 3